**Core Concept:** Wolff-Parkinson-White (WPW) syndrome is a pre-excitation syndrome characterized by an accessory (ectopic) pathway between the atria and ventricles. Patients with high-risk properties face a higher risk of life-threatening arrhythmias, such as life-threatening tachycardias, hemodynamic compromise, or hemodynamic instability.

**Why the Correct Answer is Right:** The correct answer is the treatment of choice for managing high-risk patients with WPW syndrome. In such cases, the goal of the treatment is to suppress the accessory pathway and prevent life-threatening arrhythmias. Ablation of the accessory pathway is the preferred option due to its effectiveness, safety, and long-term success.

**Why Each Wrong Option is Incorrect:**

A. Beta-blockers: Although beta-blockers can control symptoms like palpitations and exertional syncope, they do not eliminate the accessory pathway or prevent the life-threatening arrhythmias associated with WPW syndrome.

B. Antiarrhythmic drugs: Selective antiarrhythmic drugs like flecainide, propafenone, or sotalol are often ineffective in the management of WPW syndrome, as they target specific ion channels involved in the initiation and maintenance of the arrhythmia. However, they may not be as effective in high-risk patients due to the additional need for complete accessory pathway ablation.

C. Electrical cardioversion: Electrical cardioversion is typically used for atrial flutter or atrial fibrillation, not for WPW syndrome. Ablation is the preferred treatment for WPW syndrome.

D. Surgery: Surgery, such as surgical ablation, is not the first-line treatment for WPW syndrome. Ablation using radiofrequency energy is a safer and more effective option with fewer complications.

**Clinical Pearl:** Wolff-Parkinson-White syndrome is an electrophysiological disorder that requires a targeted treatment approach tailored to the specific clinical scenario. The correct treatment depends on the patient's symptoms, hemodynamic status, and the presence of life-threatening arrhythmias. In high-risk patients, ablation of the accessory pathway is the preferred treatment option.

**Correct Answer Explanation:**

In patients with Wolff-Parkinson-White syndrome presenting with life-threatening arrhythmias, ablation of the accessory pathway is the treatment of choice. Ablation involves the use of radiofrequency energy to destroy the electrophysiological connection between the atria and ventricles, thereby preventing the development of life-threatening arrhythmias. This treatment approach is more effective than pharmacotherapy or surgical intervention in preventing life-threatening arrhythmias and stabilizing the patient's hemodynamics.